Form 8-K - Current report:
SEC Accession No. 0001193805-25-000787
Filing Date
2025-06-04
Accepted
2025-06-04 16:07:37
Documents
13
Period of Report
2025-06-04
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e664589_8k-immunic.htm   iXBRL 8-K 32075
2 e664589_ex10-1.htm EX-10.1 227535
  Complete submission text file 0001193805-25-000787.txt   470309

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE imux-20250604.xsd EX-101.SCH 3002
4 XBRL LABEL FILE imux-20250604_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE imux-20250604_pre.xml EX-101.PRE 22350
15 EXTRACTED XBRL INSTANCE DOCUMENT e664589_8k-immunic_htm.xml XML 3785
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 251023183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)